Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated May 16, 2023, relating to the financial statements of Altamira Therapeutics Ltd., appearing in the Annual Report on Form 20-F of Altamira Therapeutics Ltd. for the year ended December 31, 2023.
Deloitte AG
| /s/ Roland Mueller | /s/ Adrian Kaeppeli | ||
| Auditor in Charge |
Zurich, Switzerland
April 10, 2024